Company intelligence / Profile preview
Bordoloi Biotech
New Delhi, Delhi, Indiabordoloibiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bordoloi Biotech develops proprietary chemical and material solutions targeting unmet needs in inflammation/pain management and tissue engineering/hemostasis. The company holds granted US patents and seeks both commercial development partners and licensees. No published clinical trial results or approved products are listed publicly as of now.
- Therapeutic areas
- ImmunologyNeurologyHematology
- Modalities
- Small molecules (chemistry solutions for biological systems)Medical devices/materials for tissue engineering and hemostasis
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Seeking licensing/commercialization partners; no major pharma/biotech partnerships disclosed publicly as of May 2025.
Beyond the preview
Go deeper on Bordoloi Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bordoloi Biotech.